2023
DOI: 10.3390/ijms24098384
|View full text |Cite
|
Sign up to set email alerts
|

Applications of the Whole-Cell System in the Efficient Biosynthesis of Heme

Abstract: Heme has a variety of functions, from electronic reactions to binding gases, which makes it useful in medical treatments, dietary supplements, and food processing. In recent years, whole-cell system-based heme biosynthesis methods have been continuously explored and optimized as an alternative to the low-yield, lasting, and adverse ecological environment of chemical synthesis methods. This method relies on two biosynthetic pathways of microbial precursor 5-aminolevulinic acid (C4, C5) and three known downstrea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 115 publications
0
2
0
Order By: Relevance
“…The precursor for heme synthesis is 5-aminolevulinic acid (5-ALA). Depending on the species, the synthesis of 5-ALA can occur via the C5 pathway or the C4 pathway ( Su et al, 2023 ). Most bacteria use the C5 pathway, which involves the catalysis of glutamyl-tRNA synthetase (GltX), glutamyl-tRNA reductase (HemA), and glutamate-1-semialdehyde aminotransferase (HemL) to convert L-glutamate into 5-ALA ( Yang et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…The precursor for heme synthesis is 5-aminolevulinic acid (5-ALA). Depending on the species, the synthesis of 5-ALA can occur via the C5 pathway or the C4 pathway ( Su et al, 2023 ). Most bacteria use the C5 pathway, which involves the catalysis of glutamyl-tRNA synthetase (GltX), glutamyl-tRNA reductase (HemA), and glutamate-1-semialdehyde aminotransferase (HemL) to convert L-glutamate into 5-ALA ( Yang et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Given the commercial value and applicability of heme, its bio-based production has been explored [10]. While E. coli can be extensively engineered for enhanced heme biosynthesis, the overproduced heme is hard to secrete and tends to accumulate intracellularly, resulting in physiological toxicity to the production host and, therefore, limited production yield [11,12]. Such technical limitation prompted us to look for alternative porphyrins that could be extracellularly secreted for overproduction in E. coli.…”
Section: Introductionmentioning
confidence: 99%